Matthew H. Kulke

3 ta ish

Boston University

1. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

   Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam +24

   Sharh maqola20234 iqtibos

   ABIABI:AkademIndex/2026.other.281967

2. Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

   Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin +32

   MaqolaOAOchiq kirish20173 iqtibos

   ABIABI:AkademIndex/2026.other.011754

3. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer

   Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs +15

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.630170